Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 900 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2015

Year Title Authors Publication
2015 Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802 Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ Biol Blood Marrow Transplant 21(6):1029-1036
2015 Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Chen Y-B, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, Artz A, Bredeson CN, Cooke KR, Ho VT, Lazarus HM, Olsson R, Saber W, McCarthy P, Pasquini MC Biol Blood Marrow Transplant 21(6):1046-1053
2015 Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, Dalissier A, Davis JH, Eames GM, Egeler RM, Filipovich AH, Fischer A, Jürgens H, Krance R, Lanino E, Leung WH, Matthes S, MIchel G, Orchard PJ, Pieczonka A, Ringdén O, Schlegel PG, Sirvent A, Vettenranta K, Eapen M Br J Haematol 169(5):711-718
2015 Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL Bone Marrow Transplant
2015 Transplant outcomes for children with hypodiploid acute lymphoblastic leukemia. Mehta PA, Zhang M-J, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Pérez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, Lund TC, Leung WH, Davies SM Biol Blood Marrow Transplant
2015 Prospective validation of the predictive power of the hematopoietic cell transplantation comorbidity index: a CIBMTR® study. Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz M, Pasquini MC Biol Blood Marrow Transplant
2015 Patient centeredness and engagement in quality-of-care oncology research. Clauser SB, Gayer C, Murphy E, Majhail NS, Baker KS J Oncol Pract
2015 Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, Palmer J, Pasquini M, Rizzo DJ, Saber W, Hari P, Fenske TS Bone Marrow Transplant
2015 ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang M-J, Spellman SR, Lee SJ, Miklos DB Biol Blood Marrow Transplant 21(4):746-754
2015 Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma. Costa LJ, Huang J-X, Hari PN Biol Blood Marrow Transplant 21(4):701-706
2015 Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals. Li J, Scheike TH, Zhang M-J Lifetime Data Anal 21(2):197-217
2015 Group sequential tests for long-term survival comparisons. Logan BR, Mo S Lifetime Data Anal 21(2):218-240
2015 Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn J-Y, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME Biol Blood Marrow Transplant 21(4):640-645
2015 Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation. Ballen KK, Logan BR, Laughlin MJ, He W, Ambruso DR, Armitage SE, Beddard RL, Bhatla D, Hwang WYK, Kiss JE, Koegler G, Kurtzberg J, Nagler A, Oh D, Petz LD, Price TH, Quinones RR, Ratanatharathorn V, Rizzo JD, Sazama K, Scaradavou A, Schuster MW, Sender LS, Shpall EJ, Spellman SR, Sutton M, Weitekamp LA, Wingard JR, Eapen M Biol Blood Marrow Transplant 21(4):688-695
2015 New cancers after autotransplantations for multiple myeloma. Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang M-J, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN Biol Blood Marrow Transplant 21(4):738-745
2015 A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JLM, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ Biol Blood Marrow Transplant 21(4):761-767
2015 Hematopoietic cell transplantation for acute leukemia: selecting donors. Eapen M Haematologica 100(4):414-415
2015 Guidelines for defining and implementing standard episode of care for hematopoietic stem cell transplantation within the context of clinical trials. Majhail NS, Giralt S, Bonagura A, Crawford S, Farnia S, Omel JL, Pasquini M, Saber W, LeMaistre CF Biol Blood Marrow Transplant 21(4):583-588
2015 Editorial: To the memory of John P. Klein. Keiding N, Andersen PK, Zhang MJ Lifetime Data Anal 21(2):157-159
2015 The sequence of cyclophosphamide and myeloablative total body irradiation in hematopoietic cell transplant for patients with acute leukemia. Holter-Chakrabarty JL, Pierson N, Zhang M-J, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KM, Pasquini MC, McCarthy PL Biol Blood Marrow Transplant
2015 Secondary solid cancer screening following hematopoietic cell transplantation. Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers MED, Majhail NS Bone Marrow Transplant
2015 Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringdén OTH, Pasquini MC, Schriber JR, Cooke KR Leukemia
2015 Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the ASBMT. Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L, Sengsayadeth S, Abidi M, Hari P, Mohty M, Chen Y-B, Koreth J, Landau H, Lazarus H, Leather H, Majhail N, Nath R, Osman K, Perales M-A, Schriber J, Shaughnessy P, Vesole D, Vij R, Wingard J, Giralt S, Savani B Biol Blood Marrow Transplant
2015 Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? Sucheston-Campbell LE, Clay A, McCarthy PL, Zhu Q, Preus L, Pasquini M, Onel K, Hahn T Curr Hematol Malig Rep 10(1):45-58
2015 Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems. Besse KL, Preussler JM, Murphy EA, Denzen EM, Lill MC, Chell JW, Senneka MK, Majhail NS, Williams EP J Oncol Pract 11(2):e120-e130
2015 Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. Copelan EA, Avalos BR, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn J-Y, Khoury HJ, Weisdorf DJ, Inamoto Y, Kamble RT, Schouten HC, Wirk B, Litzow MR, Aljurf MD, van Besien KW, Ustun C, Bolwell BJ, Bredeson CN, Fasan O, Ghosh N, Horowitz MM, Arora M, Szer J, Loren AW, Alyea EP, Cortes J, Maziarz RT, Kalaycio ME, Saber W Biol Blood Marrow Transplant 21(3):552-558
2015 Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders. Hong S, Le-Rademacher J, Artz A, McCarthy PL, Logan BR, Pasquini MC Bone Marrow Transplant 50(3):367-374
2015 Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research study. Bejanyan N, Weisdorf DJ, Logan BR, Wang H-L, Devine SM, de Lima M, Bunjes DW, Zhang M-J Biol Blood Marrow Transplant 21(3):454-459
2015 Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. Gadalla SM, Wang T, Haagenson M, Spellman SR, Lee SJ, Williams KM, Wong JY, De Vivo I, Savage SA JAMA 313(6):594-602
2015 Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B, Munker R, Rizzieri DA, Chen Y-B, Gibson J, Akpek G, Costa LJ, Kamble RT, Aljurf MD, Hsu JW, Cairo MS, Schouten HC, Bacher U, Savani BN, Wingard JR, Lazarus HM, Laport GG, Montoto S, Maloney DG, Smith SM, Brunstein C, Saber W Bone Marrow Transplant 50(2):197-203
2015 Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation. Kornblit B, Enevold C, Wang T, Spellman S, Haagenson M, Lee SJ, Müller K Biol Blood Marrow Transplant 21(2):259-265
2015 Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ Biol Blood Marrow Transplant 21(2):266-274
2015 Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. Vij R, Kumar S, Zhang M-J, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN Biol Blood Marrow Transplant 21(2):335-341
2015 Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE J Clin Oncol 33(4):364-369
2015 Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. Barker JN, Fei M, Karanes C, Horwitz M, Devine S, Kindwall-Keller TL, Holter J, Adams A, Logan B, Navarro WH, Riches M Br J Haematol 168(3):405-412
2015 Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014. Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM Biol Blood Marrow Transplant 21(2):202-224
2015 Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, Mendizabal A, Laport GG, Pasquini MC, Spellman SR Biol Blood Marrow Transplant 21(1):4-7
2015 Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Majhail NS, Chitphakdithai P, Logan B, King R, Devine S, Rossmann SN, Hale G, Hartzman RJ, Karanes C, Laport GG, Nemecek E, Snyder EL, Switzer GE, Miller J, Navarro W, Confer DL, Levine JE Biol Blood Marrow Transplant 21(1):142-150
2015 Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes. Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn J-Y, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML Biol Blood Marrow Transplant 21(1):151-158
2015 Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL Biol Blood Marrow Transplant 21(1):165-171
2015 Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy. Eapen M, Logan BR, Appelbaum FR, Antin JH, Anasetti C, Couriel DR, Chen J, Maziarz RT, McCarthy PL, Nakamura R, Ratanatharathorn V, Vij R, Champlin RE Biol Blood Marrow Transplant 21(1):55-59
2015 8/8 and 10/10 high-resolution match rate for the Be The Match Unrelated Donor Registry. Dehn J, Buck K, Maiers M, Confer D, Hartzman R, Kollman C, Schmidt AH, Yang SY, Setterholm M Biol Blood Marrow Transplant 21(1):137-141
2015 Is ‘informed consent’ an ‘understood consent’ in hematopoietic cell transplantation? D'Souza A, Pasquini M, Spellecy R Bone Marrow Transplant 50(1):10-14
 
 
​​​​​

  Search Publications


View current and planned studies
Last Updated: 3/9/2015 8:24 AM